Laurus Labs Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-10-28 | +871.83 | +643.35 |
| 2026-10-27 | −1462.49 | +2609.57 |
| 2026-10-26 | −1462.49 | +2609.57 |
| 2026-10-23 | +887.65 | +3235.36 |
| 2026-10-22 | −3458.70 | +2891.32 |
Today's Institutional Flow
On October 28, 2026, foreign institutional investors (FII) recorded a net cash inflow of ₹871.83 crore, while domestic institutional investors (DII) added a net cash inflow of ₹643.35 crore to the market in equities during the session. Both categories contributed positively to overall market liquidity, indicating a broadly supportive trading environment despite broader macro‑economic uncertainties that have been prevalent in recent weeks for equities. The simultaneous rise in foreign and domestic cash participation suggests that investors are reinforcing bullish sentiment rather than reallocating capital across asset classes in the Indian market.
Trend vs 5-Day Average
Today's FII cash inflow contrasts sharply with its five‑day average of a ₹894.74 crore outflow, marking a reversal of recent net selling pressure this week. Conversely, DII cash activity remains modest relative to its five‑day average of a ₹2,592.03 crore inflow, indicating that domestic investors are still accumulating at a slower pace currently.
F&O Positioning Data
FII futures and options (F&O) positions show a net long of approximately ₹643,395 crore, reflecting substantial speculative exposure in the derivatives market across multiple contracts. The index futures long‑short ratio stands at 1.2, implying that for every short contract there are roughly 1.2 long contracts, a mild bullish tilt in the near term.
Healthcare Sector Flow
Within the healthcare sector, recent weeks have seen FII turning net buyers while DII continues modest inflows, underscoring a generally supportive stance toward pharma equities as of the data.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28